Closing The Books On GDUFA II: How Generics Fared At US FDA Over The Last Five Years

 
• By Derrick Gingery

Approval and submission data indicate steady trends aside from one outlier year.

generic drugs bottle
About 16% of ANDA approvals in FY 2022 were first-time generic drugs. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics